We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9434:TSESoftBank Corp. Analysis

Data as of 2026-06-22 - not real-time

¥210.10

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

SoftBank Corp. trades around ¥210, well below its DCF fair value of roughly ¥339, suggesting a sizable discount. Technical indicators are bearish – the price sits under the 20‑, 50‑ and 200‑day SMAs, MACD is in a negative histogram, and RSI is near 39, indicating limited upside momentum in the near term. Fundamentally, the company delivers solid cash generation with free cash flow exceeding ¥1.6 trillion and a dividend yield of 4.18%, though a high debt‑to‑equity ratio of ~139 raises financial leverage concerns. The sector is traditionally defensive, and the stock’s beta of 0.05 points to minimal market‑related volatility, but recent commentary from CEO Masayoshi Son about a €75 billion AI infrastructure push in Europe could add a growth catalyst.
Given the undervaluation, robust dividend, and potential AI‑related upside, the medium‑ to long‑term outlook tilts positive, while short‑term price pressure and leverage suggest a cautious stance now.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical positioning (price below SMAs, negative MACD)
  • High dividend yield providing income cushion
  • Elevated debt level limiting immediate upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Potential upside from AI infrastructure investments highlighted by management
  • Strong cash flow and sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to peers and intrinsic value
  • Stable earnings and dividend yield in a defensive telecom sector
  • Long‑run growth opportunities in enterprise and AI‑enabled services

Key Metrics & Analysis

Financial Health

Profit Margin7.83%
P/E Ratio18.6
ROE16.27%
ROA3.58%
Debt/Equity138.90
P/B Ratio3.4
Op. Cash Flow¥1393.8B
Free Cash Flow¥1615.4B
Industry P/E16.7

Technical Analysis

TrendBearish
RSI38.6
Support¥207.50
Resistance¥219.70
MA 20¥213.84
MA 50¥218.12
MA 200¥218.28
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value¥338.96
Target Price¥242.53
Upside/Downside15.44%
GradeUndervalued
TypeValue
Dividend Yield4.18%

Risk Assessment

Beta0.05
Volatility17.52%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.